Financial Information

Latest Quarterly Results

Quarter Ended October 31, 2020

(20.2%)

Comparable sales decline of (21.0%) on an owned basis; comparable sales decline of (20.2%) on an owned plus licensed basis.

$4.0B

Net Sales

($0.19)

Diluted EPS of ($0.29); ($0.19) per share excluding restructuring, impairment, settlement charges and other costs.

Source:

For complete information regarding our financials, see our periodic filings.